baber/WOPTO huggingface dataset:
Patent NZ-598329-A (NZ)
Title: Method and device for utilizing biomass
Inventor: STEVANOVIC’ DRAGAN
IPC: C10J3/02
Filed: 2010-08-12
Abstract: A method for converting thermal energy from carbonaceous raw materials into mechanical work using at least a first and a second device for storing and releasing thermal energy. These devices 4, 6 are connected alternately by means of controllable valves 36, 38 at least temporarily, into a turbine branch with a downstream gas turbine. The method comprises the following steps combustion of a gas in a gas burner 1, conveyance of the flue gases formed in the gas burner through at least one of the devices 4,6 for storing thermal energy, compression, by means of a compressor, of the air fed to the devices for storing thermal energy, and introduction of compressed hot air released by at least one device into the gas turbine. The carbonaceous raw materials are gasified in a gasifier 1 to form a product gas that is fed to the gas burner 2 downstream of the gasifier 1. There is no direct gas connection between the gas turbine and the gasifier 1. The method allows the reduction of dust in the flue gases.
Patent NZ-599952-A (NZ)
Title: Ophthalmic emulsion
Inventor: KETELSON HOWARD ALLEN
IPC: C09K23/00
Filed: 2010-12-02
Abstract: 599952 Disclosed herein is an ophthalmic emulsion. The emulsion has a unique combination of ingredients that promotes the stability of small oil droplets within the emulsion. The emulsion also includes a mucoadhesive polymer that aids in delivering a lipid to the ocular surface. Specifically disclosed is an ophthalmic emulsion comprising: water forming an aqueous phase; oil forming an oil phase; a hydrophilic surfactant; a hydrophobic surfactant; a charged phospholipid; borate; and a mucoadhesive galactomannan polymer; wherein: the oil phase is in droplets within the aqueous phase and the droplets have an average diameter that is no greater than about 1000 nm, but is at least 10 nm; and the borate and galactomannan polymer cooperatively act to form a gel upon instillation of the emulsion in an eye of an individual. The emulsion has a unique combination of ingredients that promotes the stability of small oil droplets within the emulsion. The emulsion also includes a mucoadhesive polymer that aid in delivering a lipid to the ocular surface.
Patent NZ-600358-A (NZ)
Title: Topical foam composition
Inventor: LULLA AMAR
IPC: A61J1/00
Filed: 2010-11-23
Abstract: 600358 A topical foam pharmaceutical composition for rectal administration comprising rifaximin in the form of nano-sized particles, preferably having an effective particle size in the range 10 to 1000 nm is described. Also described is a method of making the composition and the use of the composition to as a medicament. Providing the composition in a pressurised dispenser having a meter for issuing a metered dose is also provided. The composition is suited for administration to the rectum, colon and/or terminal ileum of a patient for the treatment, prophylaxis, or maintenance of a disorder of the rectum, colon, terminal ileum or anus. The composition may further comprise an aqueous or non-aqueous vehicle which may be one or more phannaceutically acceptably alkanols; one or more pharmaceutically acceptable vegetable oils; or one or more phannaceutically acceptable organic esters and may further comprise surfactants, solubilizers, emulsifiers, antioxidant, preservatives, silicones, and/or 5-acetyl salicylic acid. Particularly the water soluble alkanols may be ethanol; propylene glycol; glycerol; polyethyleneglycol; polypropylene glycol; propylene glycol; a glyceryl ester; or a mixture thereof. The compositions may be prepared by: (1) heating a mixture of emulsifier and surfactant to form an oily phase; (2) separately heating a mixture of a preservative and water; (3) adding a water soluble alkanol to the preservative-water mixture and then mixing with oily phase of step (1); and (4) Adding rifaximin in the form of nanosized particles to the above mixture under stirring and adjusting the required pH to a desired value using a pH adjusting agent.
Patent NZ-603704-A (NZ)
Title: Method of providing an authenticable time-and-location indication
Inventor: CHASSAGNE OLIVIER
IPC: G01S19/09
Filed: 2011-05-31
Abstract: 603704 Disclosed is a method of providing an authenticable time-and-Iocation indication using a radio-navigation signal receiver. The method includes the following steps: a) Receiving radio-navigation signals broadcast from a plurality of radio-navigation signal sources. At least some of the radio-navigation signals contain one or more cryptographic tokens protected by encryption. These tokens are updated from time to time; b) Retrieving the cryptographic tokens from the radio-navigation signals that contain them by decryption; c) Determining positioning data based on the received radio-navigation signals. The positioning data includes geographical position and time of the radio-navigation signal receiver; d) Generating a digital authentication code using a cryptographic function which takes as inputs at least the positioning data and the retrieved cryptographic tokens; and e) Producing a data package including a first and a second parts. The first part contains the positioning data and a receiver public identifier. The second part contains the digital authentication code.
Patent NZ-603707-A (NZ)
Title: Beer-taste beverages with foam stabilized
Inventor: UMEZAWA YUSUKE
IPC: C12G3/02
Filed: 2011-05-19
Abstract: 603707 Discloses a beer flavoured beverage in which the total amount of a mugi-derived extract (malt-derived extract) component is from 0.1% to 2.0% inclusive, and the alcohol content is no more than 1.0%.
Patent NZ-606563-A (NZ)
Title: Bacterial ghosts for mediating innate immunity
Inventor: LUBITZ WERNER PROF DR
IPC: A61K39/00
Filed: 2011-08-05
Abstract: Disclosed is a use of Bacterial ghosts (BG) in the manufacture of a medicament to promote an innate immune response in the skin and/or mucosa in an individual in need thereof, wherein the bacterial ghosts are derived from an E. coli strain, wherein the innate immune response is promoted by induction of the expression and/or release of at least one innate immune modulator selected from the group consisting of antimicrobial defense molecules, pro-inflammatory cytokines, reactive nitrogen species (RNS) and reactive oxygen species (ROS).
Patent NZ-606645-A (NZ)
Title: Anti-viral compounds
Inventor: DEGOEY DAVID A
IPC: A61K31/4178
Filed: 2011-10-12
Abstract: Provided are compounds of general formula I where the variables are as described in the specification. General formula IB is an example of the structure the compounds can have. Examples of the compounds include methyl { (2S)-1-[(2S)-2-{ 5-[(2R,5R)-5-{ 2-[(2S)-1-{ (2S)-2-[(methoxycarbonyl)amino]-3-methylbutanoyl} pyrrolidin-2-yl]-1H-benzimidazol-5-yl} -1-(4-phenoxyphenyl)pyrrolidin-2-yl]-1H-benzimidazol-2-yl} pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl} carbamate and methyl { (2S)-1-[(2S)-2-(5-{ 3-[3-(3-{ 2-[(2S)-1-{ (2S)-2-[(methoxycarbonyl)amino]-3-methylbutanoyl} pyrrolidin-2-yl]-1H-imidazol-5-yl} phenyl)-1-phenylazetidin-3-yl]phenyl} -1H-imidazol-2-yl)pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl} carbamate. A particularly preferred compound is methyl { (2S,3R)-1-[(2S)-2-{ 5-[(2R,5R)-1-{ 3,5-difluoro-4-[4-(4-fluorophenyl)piperidin-1-yl]phenyl} -5-(6-fluoro-2-{ (2S)-1-[N-(methoxycarbonyl)-O-methyl-L-threonyl]pyrrolidin-2-yl} -1H-benzimidazol-5-yl)pyrrolidin-2-yl]-6-fluoro-1H-benzimidazol-2-yl} pyrrolidin-1-yl]-3-methoxy-1-oxobutan-2-yl} carbamate. The compounds are inhibitors of hepatitis C virus (HCV). Further provided are processes and intermediates for preparing the compounds and pharmaceutical compositions and methods of treatment comprising them.
Patent NZ-614547-A (NZ)
Title: Spirocyclic isoxazoline derivatives as antiparasitic agents
Inventor: BILLEN DENIS
IPC: C07D491/10
Filed: 2012-02-23
Abstract: The disclosure relates to spirocyclic isoxazoline derivatives of formula (V.1) or formula (V.2), stereoisomers thereof, veterinarily acceptable salts thereof, compositions thereof, processes for making, and their use as a parasiticide in an animal. The variables within the formula are described within the specification. Example compounds include: 1-(5’-(5-(3,5-bis(trifluoromethyl)phenyl)-5-(trifluoromethyl)-4,5-dihydroisoxazol-3-yl)-3’H-spiro[azetidine-3,1’-isobenzofuran]-1-yl)-2-(methylsulfonyl)ethanone; (R)-1-(5’-(5-(3,5-bis(trifluoromethyl)phenyl)-5-(trifluoromethyl)-4,5-dihydroisoxazol-3-yl)-3’H-spiro[azetidine-3,1’-isobenzofuran]-1-yl)-2-(methylsulfonyl)ethanone; (S)-1-(5’-(5-(3,5-bis(trifluoromethyl)phenyl)-5-(trifluoromethyl)-4,5-dihydroisoxazol-3-yl)-3’H-spiro[azetidine-3,1’-isobenzofuran]-1-yl)-2-(methylsulfonyl)ethanone; 1-(5’-(5-(3-chloro-4-fluorophenyl)-5-(trifluoromethyl)-4,5-dihydroisoxazol-3-yl)-3’l-lspiro[azetidine-3,1’-isobenzofuran]-1-yl)-2-(methylsulfonyl)ethanone; (R)-1-(5’-(5-(3-chloro-4-fluorophenyl)-5-(trifluoromethyl)-4,5-dihydroisoxazol-3-yl)-3’H-spiro[azetidine-3,1’-isobenzofuran]-1-yl)-2-(methylsulfonyl)ethanone.
Patent NZ-619480-A (NZ)
Title: Method and system for implementing near field communication
Inventor: ZHOU PENGLI
IPC: H04B11/00
Filed: 2012-11-28
Abstract: Proposed are a near field communication implementation method and system. The method includes: a sending device (10) modulating a digital signal and playing a sound signal generated by modulation; and a receiving device (20) sampling the sound signal and demodulating a sampling signal to obtain a digital signal. A binary frequency shift keying (2FSK) modulation scheme is used for the modulation procedure. The present invention can realize near field communication among mobile communication devices without an embedded near field communication (NFC) chip, which solves the problem that the hardware requirements of the existing near field communication solution are high and the application range is narrow.
Patent NZ-626218-A (NZ)
Title: A locking device
Inventor: SIMON JABER
IPC: E05B65/08
Filed: 2014-06-17
Abstract: Disclosed is a window or door lock where the lock is operable by a key lock or by a snib without use of a key, where the snib is operable by rotation of the handle. The locking device includes a moveable engagement member moveable between an engagement position for securing a panel and a disengaged position permitting opening of the panel and a lock engageable with the moveable engagement member to lock the member in the engagement position. A handle is operable to move the engagement member between the engagement position and the disengaged position when the lock is unlocked. Selective disengagement of the lock from the moveable engagement member is, at the option of the user, effected by a key or, in the absence of the lock being deadlocked by the key, by rotation of the handle in a first direction, without any other movement of the handle. Selective engagement of the lock with the moveable engagement member is, at the option of the user, effected by a key or by rotation of the handle in a second direction, without any other movement of the handle. The handle has a normal at-rest position and the first direction and the second direction extend from the at-rest position in opposite directions. The handle is spring-biased to return to the normal at-rest position. Rotation of the handle in the first direction produces the following sequence of operation: the lock is disengaged from the moveable engagement member; and the moveable engagement member is moved away from the engagement position.
Patent NZ-627161-A (NZ)
Title: Animal ear tag holder
Inventor: PACHOUD DAMIEN
IPC: A01K11/00
Filed: 2012-01-11
Abstract: Disclosed is an animal ear tag holder (1) comprises a casing (2) for stocking a plurality of tags (9) which are detachably fixed onto a tape (5), a framed window (3) arranged to frame a tag extracted from the casing for detaching from the tape, and a fasten block (4) coupled to the framed window (3) to form a slot, intended to receive the tape for a guided extraction from the casing, the framed window further forming a guide (3g) for a tool (10) for detaching and picking the tag from the tape.
Patent NZ-627178-A (NZ)
Title: New phosphate prodrugs of indolizine and pyrrole derivatives, a process for their preparation and pharmaceutical compositions containing them
Inventor: DAVIDSON JAMES EDWARD PAUL
IPC: C07D217/04
Filed: 2014-07-08
Abstract: Disclosed is phosphate containing anti-apoptotic Bcl-2 protein inhibitor compounds of general formula (I) wherein the substituents are as described in the specification. Additionally disclosed is the use of the compounds or compositions in the treatment of cancers, auto-immune disease and disease of the immune system. In one embodiment the compound is 4-[{ [3-(6-{ [(3S)-3-(morpholin-4-ylmethyl)-3,4-dihydroisoquinolin-2(1H)-yl]carbonyl} -1,3-benzodioxol-5-yl)-5,6,7,8-tetrahydroindolizin-1-yl]carbonyl} (phenyl)amino]phenyl disodium phosphate. In another embodiment the compound is 4-[{ [5-(5-chloro-2-{ [(3S)-3-(morpholin-4-ylmethyl)-3,4-dihydroisoquinolin-2(1H)-yl]carbonyl} phenyl)-1,2-dimethyl-1H-pyrrol-3-yl]carbonyl} (pyridin-4-yl)amino]phenyl disodium phosphate. In yet another embodiment the compound is 4-[(5-cyano-1,2-dimethyl-1H-pyrrol-3-yl){ [5-(5-fluoro-2-{ [(3S)-3-(morpholin-4-ylmethyl)-3,4-dihydroisoquinolin-2(1H)-yl]carbonyl} phenyl)-1,2-dimethyl-1Hpyrrol-3-yl]carbonyl} amino]phenyl disodium phosphate.
Patent NZ-630591-A (NZ)
Title: Microrna compounds and methods for modulating mir-21 activity
Inventor: BHAT BALKRISHEN
IPC: C12N15/113
Filed: 2013-04-24
Abstract: Described herein are compositions and methods for the inhibition of miR-21 activity. A compound comprising a modified oligonucleotide consisting of 8 to 22 linked nucleosides, wherein the nucleobase sequence of the modified oligonucleotide is complementary to miR-21 (SEQ ID NO: 1) and wherein the modified oligonucleotide comprises at least 8 contiguous nucleosides of the following nucleoside pattern VI, III or IV in the 5’ to 3’ orientation.
Patent NZ-713080-A (NZ)
Title: Pyridin-4-yl derivatives
Inventor: BOLLI MARTIN
IPC: A61P37/00
Filed: 2014-03-14
Abstract: The invention relates to pyridine derivatives of Formula (I) which are S1P1/EDG1 receptor agonists with reduced activity on the S1P3 receptor for use in prevention or treatment of diseases or disorders associated with an activated immune system.
Patent NZ-719766-A (NZ)
Title: A resilient bearing
Inventor: HOOKER GLEN
IPC: E04B1/98
Filed: 2014-11-07
Abstract: A resilient bearing to be positioned between a first structure and a second structure including a central connection point for connecting the resilient bearing to the first structure and a plurality of limbs extending outwardly from the central connection point to distal connection points. The resilient bearing may be formed from a single piece of elastic material adapted to dampen forces due to environmental events. A functional property of the elastic material may vary along at least some of the plurality of limbs. The angle between each of at least some of the plurality of limbs and the second structure may be between 20 and 70 degrees. Earthquakes can cause serious damage to buildings or structures and this invention reduces the damage the would be sustained by a building during an earthquake. Base isolators help minimise the effects of seismic activity by allowing movement between the ground and the building to be reduced.
Patent NZ-724764-A (NZ)
Title: Oligonucleotide compositions and methods of making the same
Inventor: RAMIYA PREMCHANDRAN H
IPC: C07H21/04
Filed: 2015-04-29
Abstract: The present disclosure provides a solid phase method of making oligonucleotides via sequential coupling cycles including at least one coupling of a dinucleotide dimer subunit to a free 3’-terminal group of a growing chain. The oligonucleotides include at least two nucleoside subunits joined by a N3’→P5’ phosphoramidate linkage. The method may include the steps of (a) deprotecting the protected 3’ amino group of a terminal nucleoside attached to a solid phase support, said deprotecting forming a free 3’ amino group; (b) contacting the free 3’ amino group with a 3’-protected amino-dinucleotide-5’-phosphoramidite dimer in the presence of a nucleophilic catalyst to form an internucleoside N3’→P5’ phosphoramidite linkage; and (c) oxidizing (e.g., sulfurizing) the linkage. The compositions produced by the subject methods may include a reduced amount of one or more (N-x) oligonucleotide products. Also provided are pharmaceutical compositions including the subject oligonucleotide compositions.
Patent NZ-727559-A (NZ)
Title: Electrostatic printing of cyclodextrin compositions
Inventor: WOOD WILLARD E
IPC: G03G9/087
Filed: 2015-06-25
Abstract: Disclosed herein are methods of electrostatically printing a cyclodextrin composition on a substrate, the method including forming an electrostatically printable composition comprising a polymer and one or more cyclodextrins, one or more cyclodextrin inclusion complexes, or a combination thereof, and electrostatically printing the composition on a substrate. Also described are electrostatically printable compositions, methods of making the compositions, printing systems employing the compositions, substrates having the composition electrostatically printed thereon, laminates thereof, and uses of the printed substrates and laminates.
Patent NZ-739254-A (NZ)
Title: Method and apparatus for communicating data in a digital chaos cooperative network
Inventor: TERRY JOHN
IPC: H04B1/00
Filed: 2016-07-18
Abstract: Technical Field: This invention relates generally to wireless communication systems and embedded wireless systems. In particular, this invention relates to embedding digital signals and digital information within digital chaos waveforms. Further, the invention relates to cooperatively networking the digital chaos signals over a wireless transmission. Technical Problem: An issue with wireless communication lies in how efficiently and reliably data can be transmitted through a channel. What is needed is a method that does not sacrifice data rate in favor of range, provides increased robustness, while improving lower probability of interception/detection (LPI/LPD). A method is further needed that exhibits improvements in a system detecting and receiving multiple signals. Gist of the solution: The present invention teaches a system and method for cooperatively networking digital chaos transmissions. The invention involves using generated digital chaos sequences as spreading sequences at a transmit side, receiving the spreaded signals at a receive side and despreading the signal, recovering signals at the receive side, comparing a stored replica of the digital chaos spreading codes to the digital chaos spreading codes used at the transmit side to, determining if the signals belong to predefined groups based on a predetermined criteria, and forwarding the signals to a group member based on its group member assignment. Use: the present invention may be utilized in any device that implements the DSSS encoding scheme.
Patent NZ-741983-A (NZ)
Title: Medical luer connector
Inventor: BONALDO JEAN
IPC: A61M5/14
Filed: 2016-10-18
Abstract: A Luer medical connector having a male Luer body for connection with a female Luer assembly which includes a female Luer body, a fluid channel insert within female Luer body, an elastomeric seal between the female Luer body and the male Luer body, and an elastomeric stopper at a proximal end of the female Luer body.
Patent NZ-756901-A (NZ)
Title: Organic slow-acting fertilizer using psyllium seed husk and method for producing the same
Inventor: WANG YOUNGSUNG
IPC: C05G3/40
Filed: 2018-03-08
Abstract: The present invention provides organic slow-acting fertilizer using psyllium seed husk and a method for producing the same. Macroelements or secondary elements selected from 12 essential nutrient elements (N, P, K, Ca, Mg, S, Fe, Mn, Cu, B, Mo, and Zn) for edible plants are extracted from each of oil cake (collectively referring to residue remaining after extraction of vegetable oil, and including soybean oil cake, palm oil cake, etc.), blood meal (livestock blood), dead fish or bonefish-containing by-products, bone meal, Dead Sea mineral, egg shell, seashell, oystershell, natural gypsum, dolomite, phyllite, and natural salt. The extract is then impregnated into a porous material such as zeolite. The resultant mixture is formed into grains and then coating with linseed oil, clay or silica, and a curing agent. A second coating step is carried out using mussel extract liquid, clay or silica, and a curing agent.
Patent OA-12191-A (OA)
Title: Marine seismic acquisition system and method.
Inventor: OEZBEK ALI
IPC: G01V1/36
Filed: 1999-05-14
Abstract: A method and system for performing a marine seismic survey is described, including towing at least one seismic streamer comprising a plurality of hydrophones distributed at average intervals of not more than 500 cm therealong in the water over the area to be surveyed; directing acoustic signals down through the water and into the earth beneath; receiving with the hydrophones seismic signals reflected from strata in the earth beneath the water; digitizing the output of each hydrophone separately; and filtering the output to reduce the noise present in the output and to generate a signal with a reduced noise content wherein the filtering process uses as further input the digitized output of at least one nearby hydrophone. The filtering is applied to single sensor recordings prior to group-forming and thus able to detect and reduce coherent noise with a coherency length of 20 meters or less. It reduces noise such as streamer or bulge noise.
Patent PT-105409-A (PT)
Title: Plataforma de serviços para apoio remoto a pessoas séniores
Inventor: AZEVEDO CARLOS MANUEL DOS SANTOS
IPC: G06Q50/00
Filed: 2010-11-26
Abstract: A GRANDE MAIORIA DAS PESSOAS COM MAIS DE 65 ANOS RECORRE AO APOIO DOS SEUS FILHOS OU A INSTITUIÇÕES. A PRESENTE INVENÇÃO INTRODUZ UMA NOVA PLATAFORMA DE SERVIÇO, BASEADA NUM PARADIGMA EM QUE EXISTEM DOIS TIPOS DE UTILIZADORES DO SERVIÇO: QUEM NECESSITA DE APOIO E QUEM PRESTA ESSE APOIO. QUEM ESTÁ A SER APOIADO, TEM UM TELEFONE COM CARACTERÍSTICAS DESENVOLVIDAS ESPECIFICAMENTE PARA ESTE TIPO DE UTILIZADORES E PERMITE O USUFRUTO DE UMA MULTIPLICIDADE DE SERVIÇOS DESENHADOS PARA PESSOAS COM MAIS DE 65 ANOS.QUEM PRESTA APOIO TEM ACESSO A UMA PLATAFORMA DE WEB SELF CARE, ONDE PODE EFECTUAR TODO O CONTROLO DO TELEFONE, BEM COMO DE TODOS OS SERVIÇOS DISPONIBILIZADOS PELA PLATAFORMA PARA DAR APOIO. ADICIONALMENTE, À CONFIGURAÇÃO DE BASE AQUI DETALHADA, A PLATAFORMA ESTÁ CONSTRUÍDA COM O INTUITO DE CRIAR UM MERCADO DE FORNECEDORES DE NOVAS FUNCIONALIDADES E UM MERCADO PUBLICITÁRIO EM TORNO DOS UTILIZADORES DO SERVIÇO PRESTADO SOBRE ESTA PLATAFORMA.
Patent RU-94001133-A (RU)
Inventor: BOGDANOV D I
IPC: B05C7/08
Filed: 1994-01-13
Abstract: FIELD: isolation of internal surfaces of building articles, for example, pipes. SUBSTANCE: devices comprises trolley with controlled turning front wheels. On trolley centrifugal driving sprayer is installed connected with pressure pipeline of reservoir for solution. Trolley travels with the help of winch. Position pickup of trolley is made in the form of capsule with free-traveling current-conducting media. The latter is electrically connected with drive of turning front wheels. EFFECT: increased reliability.
Patent RU-94007875-A (RU)
Inventor: MISHIN V V
IPC: B66C9/08
Filed: 1994-03-05
Abstract: FIELD: transport engineering; crane wheels. SUBSTANCE: wheel tyre 1 is mounted on spherical surface of center 2 through disk and is connected with center by side covers 3 and pins 5 with fitted on resilient bushings 6 installed in previously made holes in tyre disk. EFFECT: reduced specific load and wear of tyre and rail, decreased dynamic loads. 1 dwg
Patent RU-94008772-A (RU)
IPC: E04C3/12
Filed: 1994-03-04
Abstract: FIELD: civil engineering. SUBSTANCE: structure has one or several combined reinforcing members representing hollow tube with perforated walls. Perforations are sealed by plugs of materials with melting temperature between 60 and 90 C. One end of such tube is plugged, another is connected to the tank with non-combustible liquid. EFFECT: enhanced refractoriness.